Quick Answer
MANGOCEUTICALS, INC. reported Shares Outstanding of 3.25 million shares for fiscal year 2024.
MANGOCEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 3.25M | +52.0% |
| 2024 | 2.13M | -93.3% |
| 2024 | 32.02M | +2142.3% |
| 2023 | 1.43M | -89.3% |
| 2022 | 13.37M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 13.88M | -56.6% | +30.4% |
| June 30, 2025 | 10.64M | -63.5% | +11256.4% |
| May 31, 2025 | 93,731 | — | -98.7% |
| March 31, 2025 | 7.14M | -69.7% | +120.1% |
| December 31, 2024 | 3.25M | +127.3% | +52.0% |
| October 31, 2024 | 2.13M | — | -93.3% |
| September 30, 2024 | 32.02M | +90.7% | +9.9% |
| June 30, 2024 | 29.14M | +74.3% | +23.4% |
- MANGOCEUTICALS, INC. showed an increase of +52.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2024 period, MANGOCEUTICALS, INC.’s shares outstanding has declined by 75.7% (from 13.37 million shares to 3.25 million shares).
- The most recent figure is from MANGOCEUTICALS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 20, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: